FDA committee supports Roche’s lymphoma treatment
March 10, 2023Medical Communications
A committee at the FDA have voted in favour of Roche’s Polivy antibody drug targeting untreated diffuse large B cell …
FlyPharma Europe, Vienna: 2023 conference officially launched
March 9, 2023Business Services
FlyPharma Europe, Vienna: 2023 conference officially launched FlyPharma Conferences is pleased to announce its seventh event in Europe, which …
MSD presents Phase 3 data for its Investigational Activin Signaling Inhibitor, in Adults with Pulmonary Arterial Hypertension on Background Therapy
March 9, 2023Business Services
LONDON, UK, March 6, 2023 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) today announced …
GSK’s RSV vaccine ready to launch
March 9, 2023Sales and Marketing
GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …
Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline
March 9, 2023Research and Development
Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …
AstraZeneca shares positive results from Imfinzi trial
March 9, 2023Research and Development
Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …
Respiree gets FDA clearance for cardio-respiratory wearable
March 9, 2023Medical Communications
Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable. RS001 is a …
New clinical trial aims to find new endometriosis treatment
March 8, 2023Research and Development
A new clinical trial is set to begin shortly which will be a collaboration between the universities of Edinburgh, Aberdeen …
Abbott’s concussion-detecting blood test approved by FDA
March 8, 2023Medical Communications
US-based Abbott, a medical technology company, has received FDA approval for its laboratory blood test which detects traumatic brain injury …
Hospital for Special Surgery reveals 3D surface topographic scan for scoliosis patients
March 8, 2023Medical Communications
Researchers at New York City’s Hospital for Special Surgery (HSS) have found that using a 30-camera array, or 3dMD, can …
FDA grants de novo approval to Neuromod’s tinnitus device
March 8, 2023Medical Communications
The FDA has granted de novo approval to Neuromod’s Lenire device which includes Bluetooth headphones, a handheld controller and the …
Redx Announces RXC004 Topline Data From a Phase 2 Monotherapy Module
March 8, 2023Business Services
Alderley Park, UK, 8 March 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …
POLB 001 patent portfolio strengthened through granting of US patent
March 8, 2023Business Services
8 March 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …
Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases
March 7, 2023Business Services
Parma, Italy and Solna, Sweden, March 7th, 2023 – Chiesi Farmaceutici S.p.A (“Chiesi Group”) and Affibody AB (“Affibody”) today announced …
Funding to increase access to early phase clinical trials given to Yale Cancer Center
March 7, 2023Sales and Marketing
Yale Cancer Center has announced it has received collaborative funding aiming to support and increase access to early phase clinical …
Wearable sensor helps detect heart attacks
March 7, 2023Research and Development
RCE Technologies has developed a bracelet-like device that can measure levels of troponin-I in the patient’s blood, providing a more …
BioMarin receives FDA update for gene therapy for adults with severe haemophilia A
March 7, 2023Medical Communications
Global biotechnology company BioMarin Pharmaceutical has announced that it’s received an update from the FDA, detailing the extension of their …
Sooma receives FDA Breakthrough Device designation for depression therapy device
March 7, 2023Medical Communications
Finnish company Sooma Medical has received Breakthrough Device designation by the FDA for its portable, at-home neuromodulation device to treat …
Late-Breaking Phase 3 A DUE Data Show Investigational Single-Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Haemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)
March 6, 2023Business Services
BEERSE, Belgium, 6 March, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase …
Moderna chooses Oxfordshire for new UK facility
March 6, 2023Manufacturing and Production
US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is …
